ACSBG1 | Acyl-CoA synthetase bubblegum family member 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ACSM1 | Acyl-CoA synthetase medium-chain family member 1 | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ACSM3 | Acyl-CoA synthetase medium-chain family member 3 | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ACSM5 | Acyl-CoA synthetase medium-chain family member 5 | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ACSM6 | Acyl-CoA synthetase medium-chain family member 6 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ACTG2 | Actin, gamma 2, smooth muscle, enteric | Cytoskeleton related proteins Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
ACVRL1 | Activin A receptor type II-like 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM11 | ADAM metallopeptidase domain 11 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ADAM22 | ADAM metallopeptidase domain 22 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM23 | ADAM metallopeptidase domain 23 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADAM28 | ADAM metallopeptidase domain 28 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMDEC1 | ADAM-like, decysin 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS14 | ADAM metallopeptidase with thrombospondin type 1 motif, 14 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif, 15 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS16 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS4 | ADAM metallopeptidase with thrombospondin type 1 motif, 4 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif, 8 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL2 | ADAMTS-like 2 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL4 | ADAMTS-like 4 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTSL5 | ADAMTS-like 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADARB2 | Adenosine deaminase, RNA-specific, B2 (non-functional) | Predicted intracellular proteins
| | | | | Tissue enhanced |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADCY5 | Adenylate cyclase 5 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADCYAP1 | Adenylate cyclase activating polypeptide 1 (pituitary) | Predicted secreted proteins
| | | | | Tissue enhanced |
ADHFE1 | Alcohol dehydrogenase, iron containing, 1 | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ADM2 | Adrenomedullin 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
ADORA1 | Adenosine A1 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ADORA2B | Adenosine A2b receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADORA3 | Adenosine A3 receptor | FDA approved drug targets G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA1A | Adrenoceptor alpha 1A | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA1B | Adrenoceptor alpha 1B | Cancer-related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA1D | Adrenoceptor alpha 1D | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA2C | Adrenoceptor alpha 2C | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADRB3 | Adrenoceptor beta 3 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADTRP | Androgen-dependent TFPI-regulating protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AFAP1L2 | Actin filament associated protein 1-like 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
AFF2 | AF4/FMR2 family, member 2 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AGBL1 | ATP/GTP binding protein-like 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
AGBL4 | ATP/GTP binding protein-like 4 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
AGMAT | Agmatine ureohydrolase (agmatinase) | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AGMO | Alkylglycerol monooxygenase | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AGPAT9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
AGR2 | Anterior gradient 2 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGR3 | Anterior gradient 3 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AGRP | Agouti related neuropeptide | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |